Accessibility navigation


Sequential designs for phase III clinical trials incorporating treatment selection

Stallard, N. and Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X (2003) Sequential designs for phase III clinical trials incorporating treatment selection. Statistics in Medicine, 22 (5). pp. 689-703. ISSN 0277-6715

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1002/sim.1362

Abstract/Summary

Most statistical methodology for phase III clinical trials focuses on the comparison of a single experimental treatment with a control. An increasing desire to reduce the time before regulatory approval of a new drug is sought has led to development of two-stage or sequential designs for trials that combine the definitive analysis associated with phase III with the treatment selection element of a phase II study. In this paper we consider a trial in which the most promising of a number of experimental treatments is selected at the first interim analysis. This considerably reduces the computational load associated with the construction of stopping boundaries compared to the approach proposed by Follman, Proschan and Geller (Biometrics 1994; 50: 325-336). The computational requirement does not exceed that for the sequential comparison of a single experimental treatment with a control. Existing methods are extended in two ways. First, the use of the efficient score as a test statistic makes the analysis of binary, normal or failure-time data, as well as adjustment for covariates or stratification straightforward. Second, the question of trial power is also considered, enabling the determination of sample size required to give specified power. Copyright © 2003 John Wiley & Sons, Ltd.

Item Type:Article
Refereed:Yes
Divisions:Science > School of Mathematical, Physical and Computational Sciences > Department of Mathematics and Statistics > Applied Statistics
ID Code:9453
Uncontrolled Keywords:group sequential test , phase II/III trial , screening design , select and test design , spending functions

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation